Collagen synthesis pathway enzyme Overview
Collagen synthesis pathway enzymes refer collectively to the group of intracellular enzymes responsible for the post-translational modifications required for proper collagen biosynthesis. The most critical among these are **prolyl 4-hydroxylases**, **prolyl 3-hydroxylases**, and **lysyl hydroxylases**. These enzymes catalyze the hydroxylation of specific proline and lysine residues in procollagen chains within the endoplasmic reticulum. This modification is essential for stabilizing the triple-helical structure of collagen molecules through hydrogen bonding and facilitating subsequent glycosylation events[1][2][3][4][5]. Hydroxylysines also serve as sites for further glycosylation by galactosyltransferases. After secretion into the extracellular space, additional processing occurs via proteolytic cleavage by procollagen peptidases to form mature tropocollagen[9]. Cross-linking between tropocollagens is mediated by lysyl oxidase. Defects or dysregulation in these enzymes can result in connective tissue disorders such as Ehlers-Danlos syndrome or contribute to pathological fibrosis and tumor metastasis due to abnormal extracellular matrix remodeling[2]. **Note:** "Collagen synthesis pathway enzymes" is not a single molecular target but rather a functional group comprising several distinct but related enzymatic proteins involved in collagen biosynthesis. For structured data purposes, it would be more accurate to specify individual targets such as "Prolyl 4-hydroxylase" or "Lysyl hydroxylase," each with their own gene/protein identifiers (e.g., P4HA1/PLOD1)[1][2][3].
Mechanism of Action
Inhibition of enzymatic activity to reduce collagen cross-linking or stability[2]
Biological Functions
Disease Associations
Safety Considerations
- Impaired wound healing with inhibition
Interacting Drugs
Associated Biomarkers
Biomarker |
---|
Hydroxyproline levels (as a marker of collagen turnover) |